Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

Theratechnologies Inc. (THTX) had Revenue of $85.87M for the most recently reported fiscal year, ending 2024-11-30.

Quarterly Annual

Figures for fiscal year ending 2024-11-30

Income Statement Financials
Revenue	$85.87M
Net Income	$-8.31M
Cost of Goods Sold	$20.45M
Gross Profit	$65.42M
Operating Expenses	$77.69M
Operating Income	$8.17M
Non-Operating Income/Expense	$-14.47M
Pre-Tax Income	$-6.30M
Normalized Pre-Tax Income	$-6.30M
Income after Taxes	$-8.31M
Income from Continuous Operations	$-8.31M
Consolidated Net Income/Loss	$-8.31M
Normalized Income after Taxes	$-8.31M
EBIT	$8.17M
EBITDA	$10.94M
Weighted-Average Shares Outstanding (Basic)	49.36M
Weighted-Average Shares Outstanding (Diluted)	49.36M
Earnings per Share (EPS) (Basic)	$-0.17
Earnings per Share (EPS) (Diluted)	$-0.17
Balance Sheet Financials
Current Assets	$43.98M
Property, Plant, and Equipment	$0.22M
Long-Term Assets	$9.36M
Total Assets	$53.34M
Current Liabilities	$36.86M
Long-Term Debt	$40.94M
Long-Term Liabilities	$41.75M
Total Liabilities	$78.61M
Common Equity	$-25.27M
Tangible Shareholders Equity	$-32.84M
Shareholders Equity	$-25.27M
Common Shares Outstanding	45.98M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$2.38M
Cash Flow from Investing Activities	$0.94M
Cash Flow from Financial Activities	$-21.49M
Beginning Cash	$34.10M
End Cash	$15.90M
Increase/Decrease in Cash	$-18.20M
Stock-Based Compensation	$3.55M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.19
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	2.61
Debt to Equity Ratio	-1.76
Gross Margin	76.19%
Operating Margin	9.52%
EBIT Margin	9.52%
EBITDA Margin	12.73%
Pre-Tax Profit Margin	-7.34%
Profit Margin	-9.67%
Free Cash Flow	$2.38M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	1.61
Inventory Turnover	3.87
Receiveable Turnover	5.50
Days Sales in Receivables	66.33
Return on Equity	32.87%
Return on Tangible Equity	25.29%
Return on Assets	-15.57%
Return on Investments	-53.02%
Book Value Per Share	$-0.55
Free Cash Flow per Share	$0.05
Operating Cash Flow per Share	$0.05

Data from Zacks Investment Research, Inc.